TI
DNA icon

Trexquant Investment’s Ginkgo Bioworks DNA Stock Holding History

Trexquant Investment’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$178K Buy
+18,004
New +$151K ﹤0.01% 1809
2024
Q4 		– Sell
-97,401
Closed -$794K – 1616
2024
Q3 		$794K Buy
+97,401
New +$976K 0.01% 1120

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Trexquant Investment's DNA Position: Q2 2026 in Review

Trexquant Investment opened a new position in Ginkgo Bioworks (DNA) in Q2 2026: 18,004 shares worth $178K. The stake represents ﹤0.01% of the portfolio and ranks #1809 among its holdings. This is a return to the name: Trexquant Investment previously reported a position in DNA as recently as Q3 2024.

Trexquant Investment first reported a position in DNA in Q3 2024 and has held it in 2 quarters since. The position peaked at $794K in Q3 2024. 183 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Trexquant Investment held 18,004 shares of Ginkgo Bioworks worth $178K as of Q2 2026.
  • Ginkgo Bioworks was a new Trexquant Investment position in Q2 2026.
  • Ginkgo Bioworks made up ﹤0.01% of Trexquant Investment's portfolio in Q2 2026, its #1809 holding.
  • Trexquant Investment first reported a position in Ginkgo Bioworks in Q3 2024 and has held it in 2 quarters since.
  • Trexquant Investment's Ginkgo Bioworks position peaked at $794K in Q3 2024.
  • 183 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.